ChemoTech

Lund, Sweden Founded: 2015 • Age: 11 yrs
Developer of electroporation devices for the treatment of cancer

About ChemoTech

ChemoTech is a company based in Lund (Sweden) founded in 2015 by Mohan Frick.. ChemoTech offers products and services including IQwave™ and TSE Technology. ChemoTech operates in a competitive market with competitors including IGEA, Nativis, RanD and Papyrus Therapeutics, among others.

  • Headquarter Lund, Sweden
  • Founders Mohan Frick
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Chemotech Supply & Rnd Llp
  • Date of Incorporation 27 Sep, 2018
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $595.65 K (USD)
    132.67
    as on Dec 31, 2024
  • Net Profit
    $-1.24 M (USD)
    34.96
    as on Dec 31, 2024
  • EBITDA
    $-1.14 M (USD)
    37.45
    as on Dec 31, 2024
  • Latest Funding Round
    $55.99 K (USD), Grant

    Dec 31, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ChemoTech

ChemoTech offers a comprehensive portfolio of products and services, including IQwave™ and TSE Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for electroporation-based cancer treatment with enhanced drug efficacy.

Platform promoting tumour-specific electroporation for safer chemotherapy.

People of ChemoTech
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 4
Employee Profiles
People
Mohan Frick
CEO & Founder
People
Ann Ohlsson
Head, Finance
People
Eva Ståhl Wernersson
QM & RA Director
People
Marcus Orrgren
Social Media Marketing

Unlock access to complete

Funding Insights of ChemoTech

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $55,993
  • First Round

    (01 Jul 2019)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2019 Amount Grant - ChemoTech Valuation

investors

Jul, 2019 Amount Grant - ChemoTech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ChemoTech

ChemoTech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ChemoTech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ChemoTech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Chemotech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ChemoTech

ChemoTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGEA, Nativis, RanD and Papyrus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Orthopedic medical devices to promote reparative osteogenesis and joint protection
domain founded_year HQ Location
Developer of a therapeutic device for the treatment of cancer
domain founded_year HQ Location
Medical devices for surgical oncology are developed using extracorporeal technologies.
domain founded_year HQ Location
Develops therapies for tumor suppression in various cancers through scientific research.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Chemotech

Frequently Asked Questions about ChemoTech

When was ChemoTech founded?

ChemoTech was founded in 2015 and raised its 1st funding round 4 years after it was founded.

Where is ChemoTech located?

ChemoTech is headquartered in Lund, Sweden.

Who is the current CEO of ChemoTech?

Mohan Frick is the current CEO of ChemoTech. They have also founded this company.

What is the annual revenue of ChemoTech?

Annual revenue of ChemoTech is $595.65K as on Dec 31, 2024.

What does ChemoTech do?

ChemoTech was founded in 2015 in Lund, Sweden, within the medical devices sector focused on oncology. Electroporation technology is utilized to create pores in tumor cells for enhanced chemotherapy delivery through the patented IQwave device. A software platform is also provided, integrated with the device to maintain a database for analyzing various tumor types and supporting treatment protocols.

Who are the top competitors of ChemoTech?

ChemoTech's top competitors include Nativis, RanD and IGEA.

What products or services does ChemoTech offer?

ChemoTech offers IQwave™ and TSE Technology.

Who are ChemoTech's investors?

ChemoTech has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available